Aug 28, 2024
Accelerating Pediatric Drug Development- The Role of Quantitative Clinical Pharmacology
Vivpro Corporation has partnered with experts and industry leaders to discuss critical pharma and biotech topics. Our goal is to share valuable information and allow the audience to engage with questions while they receive real-time feedback.
For our August session, we are joined by Dr. Jing Liu, Senior Director, Clinical Pharmacology, Pfizer
At this WebChat you will gain insights into the following:
• Evolving global regulations on pediatric drug development
• When, what and how to plan for an efficient pediatric program
• Examples of application of quantitative clinical pharmacology to accelerate pediatric programs
• Concluding remarks
About Dr. Jing Liu
Dr. Jing Liu, PhD, is a Senior Director of Clinical Pharmacology at Pfizer Inc. with over 20 years of experience. She is known for her leadership in model-informed drug discovery and development across various diseases and drug types, having authored over 130 scientific publications. Dr. Liu holds influential roles in professional societies like the ASCPT and has contributed significantly to advancing pediatric drug development internationally.
